Find a Clinical Trial
Clinical trials may offer additional treatment options for people with lung cancer. Exploring trials early — before treatment begins — can help ensure you and your care team are aware of all available choices.
Before you begin, it helps to have a few details available. This can make your search results more accurate and easier to discuss with your care team.
Helpful information to gather:
- Your lung cancer type (for example: NSCLC or SCLC) and stage
- Any treatments you’ve already received (if any)
- Whether you’ve had biomarker or genetic testing
- Recent scan results (CT, PET, MRI) and pathology details
- Your general health and any major medical conditions
Tip: If you’re newly diagnosed, ask your doctor:
“Are there clinical trials I should consider before starting treatment?”
-
Match to clinical trials in 60 seconds
Search for a Clinical Trial with Antidote Match™
Antidote Match™ connects people with medical research studies, in the fastest and easiest way possible. All you need to do is answer a few questions, and they will find the right trials for you. You gain access to the latest medical developments and world-class care
-
Provided by the U.S. National Library of Medicine
Search for a clinical trial at ClinicalTrials.gov
ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world.
-
Something Big Is Coming
Finding the right clinical trial shouldn't feel like searching in the dark.
A powerful new tool is on its way — built to connect patients, caregivers, and advocates with the most current, relevant lung cancer trial opportunities available. Join our community to be the first to find out.
Examples of Lung Cancer Clinical Trials
There are different types of studies patients may encounter.
Studies evaluating whether adding immunotherapy to standard chemotherapy improves outcomes for certain types of lung cancer, including extensive-stage small cell lung cancer.
Trials studying treatments designed for cancers with specific genetic or molecular features.
Studies examining whether continued treatment after initial therapy helps control cancer longer.
Not sure where to start?
Take these tools with you to your next appointment.
- Questions to Ask Your Doctor About Clinical Trials
- What Happens in a Clinical Trial?
- Clinical Trials 101
Featured Trial Category:
Extensive-Stage SCLC Research
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
A randomized phase 3 trial in first‑line extensive‑stage small‑cell lung cancer of BNT327 in combination with chemotherapy>
Trial status: Recruiting | Trial Identifier: BNT327-03 | ClinicalTrials.gov Identifier: NCT06712355
A Study of Tarlatamab (AMG 757) Versus Standard of Care in Participants With Extensive-Stage Small Cell Lung Cancer After Platinum-Based Therapy (DeLLphi-306)
Trial status: Recruiting | Trial Identifier: DeLLphi-306 | ClinicalTrials.gov Identifier: NCT06117774
LCFA provides educational resources and awareness information for informational purposes only. This content does not constitute medical advice, and the mention of any treatment, therapy, clinical trial, or research does not imply endorsement by LCFA. Always consult a qualified healthcare provider before making any treatment decisions.